rs914754937

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001159699.2(FHL1):​c.737-9T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,170,211 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 72 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., 7 hem., cov: 21)
Exomes 𝑓: 0.00017 ( 0 hom. 65 hem. )

Consequence

FHL1
NM_001159699.2 intron

Scores

2
Splicing: ADA: 0.00008933
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.586

Publications

0 publications found
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
FHL1 Gene-Disease associations (from GenCC):
  • X-linked myopathy with postural muscle atrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • myopathy, reducing body, X-linked, early-onset, severe
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • reducing body myopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked scapuloperoneal muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant X-136209862-T-C is Benign according to our data. Variant chrX-136209862-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 391549.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000192 (21/109207) while in subpopulation EAS AF = 0.000575 (2/3480). AF 95% confidence interval is 0.000255. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 7 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001159699.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHL1
NM_001159702.3
MANE Plus Clinical
c.889-9T>C
intron
N/ANP_001153174.1Q13642-2
FHL1
NM_001159699.2
MANE Select
c.737-9T>C
intron
N/ANP_001153171.1Q13642-5
FHL1
NM_001440769.1
c.937-9T>C
intron
N/ANP_001427698.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHL1
ENST00000394155.8
TSL:5 MANE Plus Clinical
c.889-9T>C
intron
N/AENSP00000377710.2Q13642-2
FHL1
ENST00000370683.6
TSL:1 MANE Select
c.737-9T>C
intron
N/AENSP00000359717.1Q13642-5
FHL1
ENST00000543669.5
TSL:1
c.689-9T>C
intron
N/AENSP00000443333.1Q13642-1

Frequencies

GnomAD3 genomes
AF:
0.000192
AC:
21
AN:
109163
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.000433
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000977
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000573
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000955
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000166
AC:
28
AN:
168269
AF XY:
0.000223
show subpopulations
Gnomad AFR exome
AF:
0.000318
Gnomad AMR exome
AF:
0.000316
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000121
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000172
AC:
183
AN:
1061004
Hom.:
0
Cov.:
30
AF XY:
0.000189
AC XY:
65
AN XY:
344356
show subpopulations
African (AFR)
AF:
0.000349
AC:
9
AN:
25756
American (AMR)
AF:
0.000267
AC:
9
AN:
33687
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18802
East Asian (EAS)
AF:
0.000172
AC:
5
AN:
29087
South Asian (SAS)
AF:
0.000250
AC:
13
AN:
51990
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38765
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3581
European-Non Finnish (NFE)
AF:
0.000176
AC:
143
AN:
814756
Other (OTH)
AF:
0.0000897
AC:
4
AN:
44580
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000192
AC:
21
AN:
109207
Hom.:
0
Cov.:
21
AF XY:
0.000221
AC XY:
7
AN XY:
31737
show subpopulations
African (AFR)
AF:
0.000432
AC:
13
AN:
30082
American (AMR)
AF:
0.0000976
AC:
1
AN:
10250
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2624
East Asian (EAS)
AF:
0.000575
AC:
2
AN:
3480
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2461
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5613
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.0000956
AC:
5
AN:
52322
Other (OTH)
AF:
0.00
AC:
0
AN:
1488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000427
Hom.:
2
Bravo
AF:
0.000166

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
X-linked myopathy with postural muscle atrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.82
DANN
Benign
0.12
PhyloP100
0.59
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000089
dbscSNV1_RF
Benign
0.032
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs914754937; hg19: chrX-135292021; API